• Patients with homozygous familial hypercholesterolemia (HoFH) have increased cardiovascular risk. • Coronavirus disease 2019 (COVID-19) pandemic affected healthy life behaviors and anxiety of patients with HoFH. • Fear of COVID-19 leads to avoidance of seeking medical care. • As a hospital-based treatment, lipid apheresis is disrupted during the pandemic.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491483 | PMC |
http://dx.doi.org/10.1016/j.jacl.2020.09.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!